In a new study, published in Cell, researchers describe a newfound mechanism for creating proteins in a giant DNA virus, comparable to a mechanism in eukaryotic cells. The finding challenges the dogma ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...

RNA therapeutics target translation rather than DNA, aiming to correct shared protein production errors. By enabling cells to read through premature stop codons, engineered tRNAs could restore ...

A new research perspective was published in Volume 18 of Aging-US on February 24, 2026, titled “A decline in glycolytic ATP ...

Explore the World ADC Conference highlights on antibody-drug conjugates and their impact on cancer therapy and clinical ...

Structural nanomedicine — what helped give us the COVID vaccine — may now be the key to a potent blood cancer treatment that’s had remarkable early results.

Cambridge researchers map the convergence of biomarkers, digital phenotyping, and AI toward biologically grounded ...

Ongoing research aims to confirm the mechanism by which ICP4 fluidizes the nucleus, which could indicate specific targets to counter viral replication.

In their fall-winter 2026-2027 offerings, Michael Rider and Matthieu Blazy provide a sharp perspective on the chic wardrobe.

The origin of the nucleus remains hotly debated among scientists, but new imaging and genomic data are shedding light on this billion-year-old mystery.

Thank you, everyone, for joining us on Day 2 of the Wolfe FinTech Forum. Really happy to have Shift4 with us, a company that I'll never forget this IPO, and Chris remembers it as much as I do just ...